Sofgen Pharma S.A.
DelistedCIK 1863362fmd_0H0ZHZ5RAHYY0K6QG1HCT526SKManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2024, 8 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Total revenues | 325 | 331 | 404 | 403 | 424 | 374 |
| Cost of revenue | 142 | 140 | 174 | 168 | 186 | 182 |
| Gross profit | 182 | 191 | 230 | 235 | 238 | 191 |
| Selling, general and administrative | 145 | 128 | 164 | 198 | 193 | 223 |
| Operating income | – | – | (15) | 10 | 72 | (54) |
| Interest expense | 43 | 54 | 79 | 26 | 41 | 42 |
| Income before taxes | (10) | 1 | (94) | 48 | 46 | (85) |
| Income tax expense | 7 | 11 | 13 | 12 | 6 | (16) |
| Net income from continuing operations | (17) | (10) | (107) | 36 | 40 | (68) |
| Net income | (17) | (10) | (107) | 36 | 40 | (68) |